Tenderwize
Wróć do wyszukiwania

Open-house rebate agreements for Betamethason and antibiotics

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 218 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Betamethason und Antibiotika, ATC D07CC01

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive rebate agreements for pharmaceutical products with active substance Betamethason and antibiotics, ATC D07CC01.
  • Open-house model with uniform terms for all participants; no individual negotiations.
Pokaż pełne podsumowanie

This is an open-house pharmaceutical supply notice by AOK Rheinland-Pfalz/Saarland for non-exclusive rebate agreements on Betamethason and antibiotics (ATC D07CC01), with a 24-month maximum term and monthly entry possible. The notice explicitly states that it is not a public procurement contract under the procurement rules, but it is published for transparency. No contract value is provided. Submission is by original documents only; electronic submission is not allowed. The notice excludes medicines listed as children’s medicines under the BfArM list (§ 35 Abs. 5a SGB V).

Ryzyka

Submission by original documents is required and electronic submission is not allowed, which increases delivery and tim...

The buyer may later replace the open-house agreements with exclusive rebate agreements, causing automatic termination o...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only authorised and marketable medicines in Germany may be supplied.

Administrative

  • If a medicine is not yet listed in Lauer-Taxe at submission time, an AMIce public extract must be provided with the required information.
  • If the AMIce extract is incomplete or outdated, supplementary evidence such as approval documents, change notifications, or an affidavit must be submitted.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreements for Betamethason and antibiotics

Single lot open-house model for non-exclusive rebate agreements for medicines with the stated active substance/ATC D07CC01. The contracting buyer offers the same conditions to all interested pharmaceutical companies, with no individual negotiations. Contracts can start on the first day of each month within the 24-month period, earliest 2025-06-01, and end no later than 24 months after the earliest start date. The notice says the buyer may replace these open-house agreements with exclusive agreements later. Medicines listed as children’s medicines under the BfArM list are excluded. Eligibility-related supply proof is required for marketed medicines in Germany.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
237226-2025

Dokumenty (1)

Podobne przetargi